NEW YORK, Nov. 30, 2015 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of USA Technologies Inc. (“USA Technologies”) (NASDAQ:USAT) between September 9, 2014 and September 29, 2015.
You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Eastern District of Pennsylvania. If you purchased or otherwise acquired USA Technologies securities between September 9, 2014 and September 29, 2015, your rights may be affected by this action. To get more information go to:
http://zlk.9nl.com/usa-technologies-usat
or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose: (i) that there were significant deficiencies in both the design and operating effectiveness of the Company’s internal control over financial reporting; (ii) the deficiencies represented a material weakness in internal control; (iii) as a result of said deficiencies, the Company’s procedures failed to identify a large number of uncollectible small balance accounts; and (iv) as a result of the aforementioned, USA Technologies’ public statements were materially false and misleading at all relevant times.
If you suffered a loss in USA Technologies you have until December 1, 2015 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.